成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Biochemical and biophysical research communications >>article
Biochemical and biophysical research communications

Biochemical and biophysical research communications

IF: 2.5
Download PDF

O-GlcNAcylation of progranulin promotes Hepatocellular Carcinoma proliferation

Published:5 December 2024 DOI: 10.1016/j.bbrc.2024.151150 PMID: 39657353
Yi Liang,?Liqiong Chen,?Zhuanglin Huang,?Yueliang Li,?Hanqin Weng,?Lianxian Guo

Abstract

Progranulin (PGRN) is overexpressed and implicated in hepatocellular carcinoma (HCC) development; however, its post-translational modifications and regulatory mechanisms in HCC remain largely unexplored. Here, the expression levels of PGRN, OGT, and O-GlcNAcylation were found to be elevated in both HCC samples and cell lines. LC-MS/MS analysis and immunoprecipitation revealed that PGRN underwent O-linked N-acetylglucosamine (O-GlcNAc) modification at threonine 272 (Thr272). Co-immunoprecipitation and confocal microscopy confirmed the interaction and colocalization of O-GlcNAc transferase (OGT) with PGRN. Reducing O-GlcNAcylation increased the ubiquitination of PGRN, while increasing O-GlcNAcylation inhibited ubiquitination and elevated PGRN stability, as measured by cycloheximide (CHX) chase experiments. This regulation of PGRN stability was directly linked to its expression levels. Moreover, mutation at the primary O-GlcNAc site Thr272 inhibited the activity of the PI3K/AKT/mTOR signaling pathway and suppressed HCC cell proliferation. Together, our findings indicate that O-GlcNAcylation at Thr272 is essential for PGRN-driven HCC cell proliferation.

Substances (3)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Dimethyl sulfoxide 67-68-5 C2H6OS 1349 suppliers $15.00-$120900.00
Rapamycin 53123-88-9 C51H79NO13 870 suppliers $9.00-$6160.00
MG-132 133407-82-6 C26H41N3O5 298 suppliers $11.00-$1000.00

Similar articles

IF:3

DSN1 Interaction With Centromere‐Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma

Molecular Carcinogenesis Hongrui Zhou, Mengxue Zhang,etc Published: 19 November 2024
IF:3.3

MOTS-c relieves hepatocellular carcinoma resistance to TRAIL-induced apoptosis under hypoxic conditions by activating MEF2A

Experimental cell research Haiying Shen, Junjie Nie,etc Published: 22 November 2024